Allianz Asset Management

Allianz Asset Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Allianz Asset Management’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-10,152	Closed	-$113K	–	1983
2020 Q3	$113K	Buy	+10,152	New	+$92.9K	﹤0.01%	1802
2015 Q4	–	Sell	-86,069	Closed	-$722K	–	2544
2015 Q3	$722K	Buy	+86,069	New	+$1.37M	﹤0.01%	1946
2015 Q2	–	Sell	-35,940	Closed	-$415K	–	2542
2015 Q1	$415K	Buy	+35,940	New	+$416K	﹤0.01%	2026

Other funds holding SRNE

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Cormorant Asset Management Boston, Massachusetts $1.98B AUM 737.95% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

JP Morgan Chase

JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return